CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $21,438,000 | -73.6% | 612,500 | -30.6% | 2.44% | -66.5% |
| Q3 2015 | $81,190,000 | +11.7% | 882,891 | +6.8% | 7.26% | +37.2% |
| Q2 2015 | $72,670,000 | +18.4% | 826,919 | 0.0% | 5.29% | +41.7% |
| Q1 2015 | $61,383,000 | +38.7% | 826,919 | +4.6% | 3.74% | +42.3% |
| Q4 2014 | $44,271,000 | +23.5% | 790,555 | 0.0% | 2.63% | +2.3% |
| Q3 2014 | $35,860,000 | +9.5% | 790,555 | 0.0% | 2.57% | +22.5% |
| Q2 2014 | $32,737,000 | -40.2% | 790,555 | 0.0% | 2.10% | -38.1% |
| Q1 2014 | $54,761,000 | +14.9% | 790,555 | 0.0% | 3.39% | +23.2% |
| Q4 2013 | $47,646,000 | -0.9% | 790,555 | 0.0% | 2.75% | -3.6% |
| Q3 2013 | $48,066,000 | -22.4% | 790,555 | -14.5% | 2.85% | -22.4% |
| Q2 2013 | $61,957,000 | – | 925,000 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |